Hye Sung Won1, Chan-Kwon Jung2, Sang Hoon Chun3, Jin-Hyoung Kang4, Yeon-Sil Kim5, Dong-Il Sun6, Min-Sik Kim6. 1. Division of Medical Oncology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea. 2. Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea. 3. Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea. 4. Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea. Electronic address: jinkang@catholic.ac.kr. 5. Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea. 6. Department of Otorhinolaryngology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea.
Abstract
OBJECTIVES: The aims of this study were to evaluate the expression of EGFR, PI3K, Akt, mTOR, and PTEN in the oral cavity and oropharyngeal cancers, and to investigate their clinical significance as prognostic markers. MATERIALS AND METHODS: One hundred twenty-one patients who underwent curative surgery for oral cavity or oropharyngeal squamous cell carcinoma in Seoul St. Mary's Hospital between January 1995 and September 2009 were evaluated. The level of protein expression of EGFR, PIK3CA, pAkt, mTOR, and PTEN was assessed by immunohistochemistry. In situ hybridization was used to detect the existence of human papillomavirus (HPV). RESULTS: Nineteen of 61 patients with oropharyngeal cancer showed HPV-positive tumors, and two of 60 patients with oral cavity cancer showed HPV-positive tumors. EGFR and pAkt expression was significantly higher in oral cavity cancers than in oropharyngeal cancers. Loss of PTEN occurred significantly more frequently in oral cavity cancers than in oropharyngeal cancers. The expression levels of PIK3CA, mTOR, and p53 did not differ significantly between the two cancers. Overexpression of EGFR and pAkt and loss of PTEN were observed more frequently in HPV-negative tumors. Multivariate Cox regression analysis showed that pAkt expression had a significantly unfavorable impact on relapse-free survival in oropharyngeal cancer. CONCLUSION: We conclude that the expression levels of EGFR, pAkt, and PTEN differ between oropharyngeal and oral cavity cancer and it may be attributed to HPV-related molecular pathogenesis. The expression of pAkt might be an unfavorable prognostic marker for relapse-free survival in oropharyngeal cancer.
OBJECTIVES: The aims of this study were to evaluate the expression of EGFR, PI3K, Akt, mTOR, and PTEN in the oral cavity and oropharyngeal cancers, and to investigate their clinical significance as prognostic markers. MATERIALS AND METHODS: One hundred twenty-one patients who underwent curative surgery for oral cavity or oropharyngeal squamous cell carcinoma in Seoul St. Mary's Hospital between January 1995 and September 2009 were evaluated. The level of protein expression of EGFR, PIK3CA, pAkt, mTOR, and PTEN was assessed by immunohistochemistry. In situ hybridization was used to detect the existence of human papillomavirus (HPV). RESULTS: Nineteen of 61 patients with oropharyngeal cancer showed HPV-positive tumors, and two of 60 patients with oral cavity cancer showed HPV-positive tumors. EGFR and pAkt expression was significantly higher in oral cavity cancers than in oropharyngeal cancers. Loss of PTEN occurred significantly more frequently in oral cavity cancers than in oropharyngeal cancers. The expression levels of PIK3CA, mTOR, and p53 did not differ significantly between the two cancers. Overexpression of EGFR and pAkt and loss of PTEN were observed more frequently in HPV-negative tumors. Multivariate Cox regression analysis showed that pAkt expression had a significantly unfavorable impact on relapse-free survival in oropharyngeal cancer. CONCLUSION: We conclude that the expression levels of EGFR, pAkt, and PTEN differ between oropharyngeal and oral cavity cancer and it may be attributed to HPV-related molecular pathogenesis. The expression of pAkt might be an unfavorable prognostic marker for relapse-free survival in oropharyngeal cancer.
Authors: Ann Margaret V Chang; Marina N Nikiforova; Jonas T Johnson; Julie E Bauman; Bayardo Perez-Ordonez; Raja R Seethala; Jeffrey F Krane; Simion I Chiosea Journal: Head Neck Pathol Date: 2013-11-21
Authors: Sofia Lyford-Pike; Shiwen Peng; Geoffrey D Young; Janis M Taube; William H Westra; Belinda Akpeng; Tullia C Bruno; Jeremy D Richmon; Hao Wang; Justin A Bishop; Lieping Chen; Charles G Drake; Suzanne L Topalian; Drew M Pardoll; Sara I Pai Journal: Cancer Res Date: 2013-01-03 Impact factor: 12.701
Authors: Matthew G Fury; Eric Sherman; Alan L Ho; Han Xiao; Frank Tsai; Oby Nwankwo; Camelia Sima; Adrian Heguy; Nora Katabi; Sofia Haque; David G Pfister Journal: Cancer Date: 2013-02-13 Impact factor: 6.860
Authors: Aristidis Asimomytis; Maria Karanikou; Alexander Rodolakis; Anna Vaiopoulou; Paraskevi Tsetsa; George Creatsas; Theodoros Stefos; Aristidis Antsaklis; Efstratios Patsouris; George Z Rassidakis Journal: Oncol Lett Date: 2016-08-29 Impact factor: 2.967
Authors: Simion I Chiosea; Jennifer R Grandis; Vivian W Y Lui; Brenda Diergaarde; Jessica H Maxwell; Robert L Ferris; Seungwon W Kim; Alyssa Luvison; Megan Miller; Marina N Nikiforova Journal: BMC Cancer Date: 2013-12-17 Impact factor: 4.430